Reported Standalone quarterly numbers for Bharat Immunologicals and Biologicals Corporation are:
Net Sales at Rs 10.48 crore in June 2022 down 26.28% from Rs. 14.22 crore in June 2021.
Story continues below Advertisement
Quarterly Net Loss at Rs. 5.00 crore in June 2022 down 359.36% from Rs. 1.93 crore in June 2021.
EBITDA stands negative at Rs. 4.68 crore in June 2022 down 462.79% from Rs. 1.29 crore in June 2021.
Bharat Immuno shares closed at 25.50 on August 24, 2022 (BSE) and has given -32.27% returns over the last 6 months and -40.56% over the last 12 months.
Story continues below Advertisement
| Bharat Immunologicals and Biologicals Corporation | | Standalone Quarterly Results | in Rs. Cr. |
|
| Jun'22 | Mar'22 | Jun'21 | | Net Sales/Income from operations | 10.48 | 22.04 | 14.22 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 10.48 | 22.04 | 14.22 | | EXPENDITURE | | Consumption of Raw Materials | 26.42 | 4.90 | 20.64 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -18.33 | 14.97 | -11.79 | | Power & Fuel | -- | -- | -- | | Employees Cost | 3.95 | 4.77 | 2.83 | | Depreciation | 0.04 | 0.06 | 0.06 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 3.27 | 0.95 | 1.49 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -4.87 | -3.60 | 0.98 | | Other Income | 0.14 | 0.51 | 0.25 | | P/L Before Int., Excpt. Items & Tax | -4.72 | -3.09 | 1.23 | | Interest | 1.58 | 1.67 | 1.16 | | P/L Before Exceptional Items & Tax | -6.30 | -4.76 | 0.07 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -6.30 | -4.76 | 0.07 | | Tax | -1.31 | -3.77 | -1.85 | | P/L After Tax from Ordinary Activities | -5.00 | -0.99 | 1.93 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -5.00 | -0.99 | 1.93 | | Equity Share Capital | 43.18 | 43.18 | 43.18 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -1.16 | -0.23 | 0.45 | | Diluted EPS | -1.16 | -- | 0.45 | | EPS After Extra Ordinary | | Basic EPS | -1.16 | -0.23 | 0.45 | | Diluted EPS | -1.16 | -- | 0.45 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
